Gait Analysis in Patients With Parkinson's Disease Off Dopaminergic Therapy

Archives of Physical Medicine and Rehabilitation

Volumn 90, Issue 11, 2009, Pages 1880-1886

  Švehlík, Martin ^a,b   Zwick, Ernst B ^a   Steinwender, Gerhardt ^a   Linhart, Wolfgang E ^a   Schwingenschuh, Petra ^a   Katschnig, Petra ^a   Ott, Erwin ^a   Enzinger, Christian ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Biomechanics; Levodopa; Neurologic gait disorders; Parkinson Disease; Rehabilitation

Indexed keywords

CABERGOLINE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE;

ADULT; AGED; ANKLE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GAIT; HIP; HUMAN; KINEMATICS; KINETICS; KNEE; MALE; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; RANGE OF MOTION; VELOCITY;

AGED; ANTIPARKINSON AGENTS; BIOMECHANICS; DISABILITY EVALUATION; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; RANGE OF MOTION, ARTICULAR;

EID: 70449334538     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2009.06.017     Document Type: Article

References (27)

1. Schenkman M., Donovan J., Tsubota J., Kluss M., Stebbins P., and Butler R.B. Management of individuals with Parkinson's disease: rationale and case studies. Phys Ther 69 (1989) 944-955
2. Koller W.C., Glatt S., Vetere-Overfield B., and Hassanein R. Falls and Parkinson's disease. Clin Neuropharmacol 12 (1989) 98-105
3. Knutsson E. An analysis of Parkinsonian gait. Brain 95 (1972) 475-486
4. Murray M.P., Sepic S.B., Gardner G.M., and Downs W.J. Walking patterns of men with parkinsonism. Am J Phys Med 57 (1978) 278-294
5. Lewis G.N., Byblow W.D., and Walt S.E. Stride length regulation in Parkinson's disease: the use of extrinsic, visual cues. Brain 123 Pt 10 (2000) 2077-2090
6. Alexander G.E., DeLong M.R., and Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9 (1986) 357-381
7. Grasso R., Peppe A., Stratta F., et al. Basal ganglia and gait control: apomorphine administration and internal pallidum stimulation in Parkinson's disease. Exp Brain Res 126 (1999) 139-148
8. Steiger M.J., Thompson P.D., and Marsden C.D. Disordered axial movement in Parkinson's disease. J Neurol Neurosurg Psychiatry 61 (1996) 645-648
9. Morris M.E., Iansek R., Matyas T.A., and Summers J.J. The pathogenesis of gait hypokinesia in Parkinson's disease. Brain 117 Pt 5 (1994) 1169-1181
10. Blin O., Ferrandez A.M., Pailhous J., and Serratrice G. Dopa-sensitive and dopa-resistant gait parameters in Parkinson's disease. J Neurol Sci 103 (1991) 51-54
11. Morris M., Iansek R., McGinley J., Matyas T., and Huxham F. Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder. Mov Disord 20 (2005) 40-50
12. Peppe A., Chiavalon C., Pasqualetti P., Crovato D., and Caltagirone C. Does gait analysis quantify motor rehabilitation efficacy in Parkinson's disease patients?. Gait Posture 26 (2007) 452-462
13. Morris M.E., McGinley J., Huxham F., Collier T.J., and Iansek R. Constraints on the kinetic, kinematic and spatiotemporal parameters of gait in Parkinson's disease. Hum Mov Sci 18 (1999) 461-483
14. Sofuwa O., Nieuwboer A., Desloovere K., Willems A.M., Chavret F., and Jonkers I. Quantitative gait analysis in Parkinson's disease: comparison with a healthy control group. Arch Phys Med Rehabil 86 (2005) 1007-1013
15. Hughes A.J., Ben-Shlomo Y., Daniel S.E., and Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study [published erratum appears in Neurology 1992;42:1436]. Neurology 42 (1992) 1142-1146
16. Rowe J.B., Hughes L., Ghosh B.C., et al. Parkinson′s disease and dopaminergic therapy-differential effects on movement, reward and cognition. Brain 131 (2008) 2094-2105
17. Fahn S., and Elton R. Unified Parkinson's disease rating scale (1987), MacMillan Healthcare Information, Florham Park, NJ
18. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression, and mortality. Neurology 5 (1967) 427-442
19. Kadaba M.P., Ramakrishnan H.K., and Wootten M.E. Measurement of lower extremity kinematics during level walking. J Orthop Res 8 (1990) 383-392
20. Winter D.A. Energy generation and absorption at the ankle and knee during fast, natural, and slow cadences. Clin Orthop Relat Res 175 (1983) 147-154
21. O'Sullivan J.D., Said C.M., Dillon L.C., Hoffman M., and Hughes A.J. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function. Mov Disord 13 (1998) 900-906
22. Winter D.A. Human balance and postural control during standing and walking. Gait Posture (1995) 193-214
23. Morris M.E., Huxham F., McGinley J., Dodd K., and Iansek R. The biomechanics and motor control of gait in Parkinson disease. Clin Biomech (Bristol, Avon) 16 (2001) 459-470
24. Judge O.J., Davis III R.B., and Ounpuu S. Step length reduction in advanced age: the role of ankle and hip kinetics. J Gerontol A Biol Sci Med Sci 51 (1996) M303-M312
25. Dietz V., Leenders K.L., and Colombo G. Leg muscle activation during gait in Parkinson's disease: influence of body unloading. Electroencephalogr Clin Neurophysiol 105 (1997) 400-405
26. Scandalis T.A., Bosak A., Berliner J.C., Helman L.L., and Wells M.R. Resistance training and gait function in patients with Parkinson's disease. Am J Phys Med Rehabil 80 (2001) 38-43 quiz 44-6
27. Dietz V., Quintern J., and Berger W. Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. Brain 104 (1981) 431-449